Pivetta Emanuele, Ravetti Anna, Paglietta Giulia, Cara Irene, Buggè Federico, Scozzari Gitana, Maule Milena M, Morello Fulvio, Locatelli Stefania, Lupia Enrico
Division of Emergency Medicine and High Dependency Unit, Città della Salute e della Scienza di Torino, Molinette Hospital, 10126 Turin, Italy.
Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
Biomedicines. 2022 Oct 13;10(10):2569. doi: 10.3390/biomedicines10102569.
During the COVID-19 pandemic, use of telemedicine with the aim of reducing the rate of viral transmission increased. This proof-of-concept observational study was planned to test the feasibility of a home-based lung ultrasound (LUS) follow-up performed by patients with mild COVID-19 infection on themselves. We enrolled patients presenting to the emergency department with SARS-CoV-2 infection without signs of pneumonia and indication to discharge. Each patient received a brief training on how to perform LUS and a handheld ultrasound probe. Then, patients were contacted on a daily basis, and LUS images were acquired by the patients themselves under "teleguidance" by the investigator. Twenty-one patients were enrolled with a median age of 44 years. All evaluations were of sufficient quality for a follow up. Probability of a better LUS quality was related to higher degree (odds ratio, OR, 1.42, 95% CI 0.5-3.99) and a lower quality to evaluation time (from 0.71, 95% CI 0.55-0.92 for less than 7 min, to 0.52, 95% CI 0.38-0.7, between 7 and 10 min, and to 0.29, 95% CI 0.2-0.43, for evaluations longer than 10 min). No effect related to gender or age was detected. LUS performed by patients and remotely overseen by expert providers seems to be a feasible and reliable telemedicine tool.
在新冠疫情期间,旨在降低病毒传播率的远程医疗使用有所增加。这项概念验证性观察性研究旨在测试轻度新冠感染患者自行进行居家肺部超声(LUS)随访的可行性。我们纳入了因感染SARS-CoV-2就诊于急诊科且无肺炎体征且符合出院指征的患者。每位患者都接受了关于如何进行LUS及使用手持超声探头的简短培训。然后,研究人员每天与患者联系,患者在研究人员的“远程指导”下自行采集LUS图像。共纳入21例患者,中位年龄为44岁。所有评估质量均足以进行随访。LUS质量更好的可能性与更高的程度相关(优势比,OR,1.42,95%置信区间0.5 - 3.99),而质量较低则与评估时间相关(评估时间少于7分钟时为0.71,95%置信区间0.55 - 0.92;7至10分钟时为0.52,95%置信区间0.38 - 0.7;评估时间超过10分钟时为0.29,95%置信区间0.2 - 0.43)。未检测到与性别或年龄相关的影响。由患者自行进行且由专业人员远程监督的LUS似乎是一种可行且可靠的远程医疗工具。